Raising Awareness of Cardiac Amyloidosis

Building greater awareness of the prevalence and differential diagnosis of cardiac amyloidosis is critical to improving the timely detection, diagnosis and appropriate management of patients. A new ACC initiative targeted at the entire cardiovascular care team is designed to do just that.

The Raising Awareness and Understanding of Cardiac Amyloidosis initiative includes several tools and resources to help clinicians understand the epidemiology of the diseases, as well as contemporary approaches to diagnosis with an emphasis on noninvasive means. Other key topics include: disease course and management of heart failure and conduction disease, as well as the recently approved therapeutics for the two major types of cardiac amyloidosis: AL and ATTR.

Don't miss a focused podcast featuring Frederick L. Ruberg, MD, FACC, and Mathew S. Maurer, MD, FACC, as well as "Quick Tips" and expert analyses that further address topics like nomenclature/epidemiology, diagnosis, medical management and amyloid-specific therapies.

CathPCI Registry Data Abstraction Gets A Boost From AI

As part of efforts to help NCDR-participating hospitals and institutions improve the efficiency of data abstraction, the ACC this month announced a collaboration with Carta Healthcare as a certified software vendor for ACC's CathPCI Registry. Carta is a provider of artificial intelligence (AI)-powered clinical data abstraction technology and services.

Carta's data abstraction solution, called Atlas, uses AI to abstract data from electronic medical records, populating clinical registries with greater efficiency and accuracy than manual abstraction. As an NCDR-certified software vendor, Atlas provides seamless end-to-end submission to the CathPCI Registry, including automatic updates of the NCDR data requirements to ensure compliant data submissions.

"A key focus for the ACC Innovation Program is artificial intelligence-driven care," says John S. Rumsfeld, MD, PhD, FACC. "Our collaboration can help hospitals advance patient care and successfully respond to a changing world, while helping the ACC bring its vision of innovation and knowledge that optimizes cardiovascular care and outcomes into reality."

"It's an absolute honor to be certified by the ACC, as participation in clinical registries like the CathPCI Registry has never been more important or meaningful in improving patient outcomes," says Matt Hollingsworth, CEO and co-founder of Carta Healthcare. "With Atlas, organizations can leverage the power of AI to streamline registry population and submission, freeing up staff time and resources to focus on what's most important — caring for patients."

Visit ACC.org/InnovationProgram to learn more about Carta and other ACC Innovation Program efforts. Learn more about the CathPCI Registry, as well as other NCDR registries, ACC Accreditation Services and more at CVQuality.ACC.org.

JACC Journals Impact Continues to Grow Worldwide

The newly released 2020 Journal Citation Report highlights the continued global impact of JACC Journals, with the entire JACC family of journals ranking among the top 28 peer-reviewed cardiovascular journals worldwide.

In particular, the report showed JACC with its highest Impact Factor yet, achieving an astounding 24.094. In addition, the four longest-publishing JACC Journals – JACC, JACC: Cardiovascular Interventions (11.195), JACC: Cardiovascular Imaging (14.805) and JACC: Heart Failure (12.035) – all ranked within the top 11 among all 142 English-language cardiovascular journals worldwide.

Each journal also received above 11 in Impact Factor for the first time.

The three newer JACC Journals receiving inaugural Impact Factors this year – JACC: Clinical Electrophysiology (6.375), JACC: Basic to Translational Science (8.648) and JACC: CardioOncology (6.25) – also achieved impressive results in terms of overall ranking and in their respective specialty areas.

Visit JACC.org to read the latest issues, take part in CME/MOC activities, and access submissions guidelines.

ACC, Wondr Medical to Create New Digital Educational Channel

The ACC and Wondr Medical are collaborating to create a new digital channel on the Wondr Medical Platform that will amplify the global reach of ACC's educational content on a dynamic new platform. The partnership also provides access to ACC's world-class content to the existing clinical users of Wondr Medical.

ACC, HRS, Bristol Myers Squibb-Pfizer Alliance to Transform AFib Care in Underserved Communities

The ACC and Heart Rhythm Society (HRS), in collaboration with the Bristol Myers Squibb-Pfizer Alliance, are launching an innovative project to improve management of atrial fibrillation (AFib) in underserved communities. The TRANSFORM: Atrial Fibrillation Quality Initiative (TRANSFORM: AF) will give clinicians and health systems tools to improve adoption of guideline-directed medical therapy in targeted patient populations by putting the right resources in front of the right people at the right time to drive measurable changes in performance.